Publications Database

Adams J. B. et al. (2009)

Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A - Medical results.

BMC Clinical Pharmacology

Read Abstract (New Window) Read Full (New Window)

Adams J. B. et al. (2009)

Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B - Behavioral results.

BMC Clinical Pharmacology

9

Read Abstract (New Window) Read Full (New Window)

Adams J. B. (2007)

Summary of biomedical treatments for autism.

San Diego: CA: Autism Research Institute

American College of Medical Toxicology (2009)

American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing.

Phoenix, AZ: American College of Medical Toxicology

Read Full (New Window)

Anagnostou E. , Hansen R. L. (2011)

Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications.

Current Opinions in Pediatrics

23(6), pp. 621-627.

Read Abstract (New Window)

Baxter A. , Krenzelok E. (2008)

Pediatric fatality secondary to EDTA chelation.

Clin Toxicol (Phila).

46(10), pp. 1083-1084

Read Abstract (New Window) Read Full (New Window)

Blaucok-Busch E. et al. (2012)

Efficacy of DMSA therapy in a sample of Arab children with autistic spectrum disorder.

Maedica (Buchar)

7(3), pp. 214-221.

Read Abstract (New Window) Read Full (New Window)

Bradstreet J. J. et al. (2003)

A case-control study of mercury burden in children with autistic spectrum disorders.

Journal of American Physicians and Surgeons

8(3), pp. 76-79

Read Full (New Window)

Brent J. (2013)

Commentary on the abuse of metal chelation therapy in patients with autism spectrum disorders.

Journal of Medical Toxicology

9(4), pp. 370-372.

Read Abstract (New Window)

Brondino N. et al. (2015)

Complementary and alternative therapies for autism spectrum disorder.

Evidence Based Complementary and Alternative Medicine

Read Abstract (New Window) Read Full (New Window)

Brown M. J. et al. (2006)

Deaths resulting from hypocalcemia after administration of edetate disodium: 2003-2005.

Pediatrics

118(2), e534-536

Read Full (New Window)

Brudnak M. A. (2002)

Probiotics as an adjuvant to detoxification protocols.

Medical Hypotheses

58(5), pp. 382-385

Read Abstract (New Window)

Centers for Disease Control and Prevention (2006)

Deaths associated with hypocalcemia from chelation therapy: Texas, Pennsylvania, and Oregon, 2003--2005.

MMWR Morbibity and Mortality Weekly Report

55(8), pp. 204-207

Read Abstract (New Window) Read Full (New Window)

Davis T. N. et al. (2013)

Chelation treatment for autism spectrum disorders: A systematic review.

Research in Autism Spectrum Disorders

7(1), pp. 49-55.

Read Abstract (New Window)

Defeat Autism Now! (2005)

Treatment options for mercury metal toxicity in autism and related developmental disabilities: Consensus position paper.

San Diego: CA: Autism Research Institute

DeFilippis M. (2018)

The use of complementary alternative medicine in children and adolescents with autism spectrum disorder.

Psychopharmacology Bulletin

48(1), pp. 40-63.

Read Abstract (New Window) Read Full (New Window)

DeSoto M. (2008)

A reply to Soden et al.: your data shows autistic children have higher levels of heavy metals.

Clin Toxicol (Phila).

46(10), pp.1098, author reply 1098

Eppright T. , Sanfacon J. , Horwitz E. (1996)

Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship.

Missouri Medicine

93(3), pp. 136-138.

Read Abstract (New Window)

Fitzpatrick M. (2009)

Defeating autism: a damaging delusion.

London: Routledge

Flora S. J. , Pachauri V. (2010)

Chelation in metal intoxication.

International Journal of Environmental Research and Public Health

July, 7(7), pp. 2745-2788.

Read Full (New Window)